Business Description
Celularity Inc
NAICS : 325412
SIC : 2834
ISIN : US1511902041
Share Class Description:
CELU: Ordinary Shares - Class ATotal Employee Number:
115Description
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.15 | |||||
Equity-to-Asset | -0.36 | |||||
Debt-to-Equity | -1.08 | |||||
Debt-to-EBITDA | -0.53 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -15.97 | |||||
Beneish M-Score | -4.78 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -4.7 | |||||
3-Year EPS without NRI Growth Rate | 32.4 | |||||
3-Year FCF Growth Rate | 62.1 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 40.2 | |||||
9-Day RSI | 48.28 | |||||
14-Day RSI | 48.19 | |||||
3-1 Month Momentum % | -39.08 | |||||
6-1 Month Momentum % | -47.58 | |||||
12-1 Month Momentum % | -78.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.15 | |||||
Quick Ratio | 0.15 | |||||
Cash Ratio | 0.08 | |||||
Days Inventory | 69.64 | |||||
Days Sales Outstanding | 140.32 | |||||
Days Payable | 443.72 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -24.6 | |||||
Shareholder Yield % | 8.89 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 24.39 | |||||
Operating Margin % | -230.92 | |||||
Net Margin % | -345.45 | |||||
EBITDA Margin % | -292.52 | |||||
FCF Margin % | -49.92 | |||||
OCF Margin % | -49.92 | |||||
ROA % | -76 | |||||
ROIC % | -51.19 | |||||
3-Year ROIIC % | -30.06 | |||||
ROC (Joel Greenblatt) % | -122.32 | |||||
ROCE % | -154.06 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.7 | |||||
EV-to-EBIT | -0.66 | |||||
EV-to-EBITDA | -0.73 | |||||
EV-to-Revenue | 2.13 | |||||
EV-to-Forward-Revenue | 5.27 | |||||
EV-to-FCF | -4.26 | |||||
Price-to-GF-Value | 0.32 | |||||
Earnings Yield (Greenblatt) % | -151.52 | |||||
FCF Yield % | -61.05 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CELU
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Celularity Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 26.55 | ||
| EPS (TTM) ($) | -3.59 | ||
| Beta | 1.113 | ||
| 3-Year Sharpe Ratio | -0.18 | ||
| 3-Year Sortino Ratio | -0.26 | ||
| Volatility % | 113.34 | ||
| 14-Day RSI | 48.19 | ||
| 14-Day ATR ($) | 0.072716 | ||
| 20-Day SMA ($) | 0.725555 | ||
| 12-1 Month Momentum % | -78.6 | ||
| 52-Week Range ($) | 0.5601 - 4.31 | ||
| Shares Outstanding (Mil) | 28.95 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Celularity Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Celularity Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| General meeting for 2026 | 2026-12-18 09:00 | In 147 days | ||
| Third quarter earnings results for 2026 | 2026-11-13 | In 111 days | ||
| First quarter earnings results for 2026 | 2026-08-28 | In 34 days | ||
| Second quarter earnings results for 2026 | 2026-08-28 | In 34 days | ||
| Annual report for 2025 | 2026-05-08 | 0.91 (-1.36%) | ||
| General meeting for 2025 | 2025-12-19 09:00 | 1.25 (-2.34%) | ||
| Third quarter earnings results for 2025 | 2025-11-14 | 1.59 (-5.92%) | ||
| First quarter earnings results for 2025 | 2025-08-29 | 3.85 (-3.51%) | ||
| Second quarter earnings results for 2025 | 2025-08-29 | 3.85 (-3.51%) | ||
| Annual report for 2024 | 2025-05-08 | 1.67 (-1.76%) |
Show
Entries
Celularity Inc Frequently Asked Questions
What is Celularity Inc(CELU)'s stock price today?
The current price of CELU is $0.75. The 52 week high of CELU is $4.31 and 52 week low is $0.56.
When is next earnings date of Celularity Inc(CELU)?
The next earnings date of Celularity Inc(CELU) is 2026-08-28 Est..
Does Celularity Inc(CELU) pay dividends? If so, how much?
Celularity Inc(CELU) does not pay dividend.
Guru Commentaries on NAS:CELU
No articles.
Press Release
Articles on Celularity Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers